Search Results - "Arega, Aregitu Mekuriaw"

Glycoconjugates, hypothetical proteins, and post‐translational modification: Importance in host–pathogen interaction and antitubercular intervention development by Arega, Aregitu Mekuriaw, Mahapatra, Rajani Kanta

“…With the emergence of multidrug‐resistant bacteria, insufficiency of the established chemotherapy, and the existing vaccine BCG, tuberculosis (TB) subsists as…”
Get full text

An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis by Arega, Aregitu Mekuriaw, Dhal, Ajit Kumar, Pattanaik, Kali Prasad, Nayak, Sasmita, Mahapatra, Rajani Kanta

“…Mycobacterium tuberculosis (Mtb) is the pathogen that causes tuberculosis and develops resistance to many of the existing drugs. The sole licensed TB vaccine,…”
Get full text

Correction to: An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis by Arega, Aregitu Mekuriaw, Dhal, Ajit Kumar, Pattanaik, Kali Prasad, Nayak, Sasmita, Mahapatra, Rajani Kanta

Get full text

Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis by Arega, Aregitu Mekuriaw, Pattanaik, Kali Prasad, Nayak, Sasmita, Mahapatra, Rajani Kanta

“…•The study is based on candidate vaccine discovery using a bioinformatics approach.•Five proteins were screened as potent vaccine candidates in M. tuberculosis…”
Get full text

In silico and in vitro study of Mycobacterium tuberculosis H37Rv uncharacterized protein (RipD): an insight on tuberculosis therapeutics by Arega, Aregitu Mekuriaw, Dhal, Ajit Kumar, Nayak, Sasmita, Mahapatra, Rajani Kanta

“…Tuberculosis caused by  Mycobacterium tuberculosis  ( Mtb ) is responsible for the highest global health problem, with the deaths of millions of people. With…”
Get full text